Literature DB >> 32186017

Data mining in Xu Runsan's Traditional Chinese Medicine practice: treatment of chronic pelvic pain caused by pelvic inflammatory disease.

Liuqing Liu1, Fang Yang2, Yan Jing2, Ling Xin3.   

Abstract

OBJECTIVE: To research the Traditional Chinese Medicine (TCM) practice of Professor Xu Runsan for treatment of chronic pelvic pain (CPP) caused by sequelae of pelvic inflammatory disease (SPID) by data mining.
METHODS: The medical records of inpatients at China-Japan Friendship Hospital confirmed to have CPP caused by SPID were collected (274 visits in total). The data extracted from the medical records were analyzed by frequency statistics, correlation analyses, cluster analyses, and complex network analyses.
RESULTS: The most frequently used medicines were warm medicines, bitter medicines, and medicines distributed to the liver meridian. The most common medicinal combinations were Chishao (Radix Paeoniae Rubra) plus Huangqi (Radix Astragali Mongolici) plus Sanqi (Radix Notoginseng) and Ezhu (Rhizoma Curcumae Phaeocaulis); Guizhi (Ramulus Cinnamomi) plus Fuling (Poria) and Chishao (Radix Paeoniae Rubra); and Chaihu (Radix Bupleuri Chinensis) plus Zhishi (Fructus Aurantii Immaturus) and Gancao (Radix Glycyrrhizae). The most frequently used medicines were divided into four groups according to their efficacy; i.e., medicines that could (a) warm meridians and free collateral vessels, (b) regulate Qi and free collateral vessels, (c) fortify the spleen and nourish blood and Qi, and (d) tonify Qi and activate blood. The most commonly used formulations were Guizhi FulingPill and Sini Powder. The core medicines extracted based on complex network analyses were Chishao (Radix Paeoniae Rubra), Sanqi (Radix Notoginseng), Huangqi (Radix Astragali Mongolici), Danshen (Radix Salviae Miltiorrhizae), Ezhu (Rhizoma Curcumae Phaeocaulis), Gancao (Radix Glycyrrhizae), Chaihu (Radix Bupleuri Chinensis), Guizhi (Ramulus Cinnamomi), Shuizhi (Hirudo), Fuling (Poria), and Zhishi (Fructus Aurantii Immaturus).
CONCLUSION: According to the TCM practice of Professor Xu, treatment of CPP caused by SPID should focus on dissolving stasis and obstructionsusing medicines that can activate blood, resolve stasis, regulate Qi, and dissipate adhesions. His prescriptions are often based on Guizhi Fuling Pill and Sini Powder. More blood-activating, stasis-resolving, or tonifying medicines could be used according to the accompanying symptoms or symptom patterns identified.

Entities:  

Keywords:  Cluster analysis; Complex network analysis; Drugs, Chinese herbal; Pelvic inflammatory disease; Pelvic pain

Year:  2019        PMID: 32186017

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  5 in total

1.  Research on Optimization of Process Parameters of Traditional Chinese Medicine Based on Data Mining Technology.

Authors:  Xue Li; Hao Yue; Jinlong Yin; Yan Song; Jinling Yin; Xinlei Zhu; Bingchang Huang
Journal:  Comput Intell Neurosci       Date:  2022-03-02

2.  A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.

Authors:  Xiaofeng Yin; Jinchuan Li; Zheng Hao; Rui Ding; Yanan Qiao
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

3.  Shipi Shugan Decoction Protected against Sequela of Pelvic Inflammatory Disease via Inhibiting SIRT1/NLRP3 Signaling Pathway in Pelvic Inflammatory Disease Rats.

Authors:  Yan Wang; Yefang Huang; Ling Shi; Li Huang; Yi Wen; Yihong Cao; Zi Yang; Qian Liu; Xiaolan Yin; Xiaoli Ji
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-05       Impact factor: 2.650

4.  Xiaoai Jiedu Recipe suppresses hepatocellular carcinogenesis through the miR-200b-3p /Notch1 axis.

Authors:  Wenli Qiu; Zhongqiu Wang; Rong Chen; Haibo Shi; Yanxia Ma; Hongli Zhou; Muhan Li; Wenting Li; Haibin Chen; Hongguang Zhou
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989

5.  Quantification of "Cold-Hot" Medicinal Properties of Chinese Medicines Based on Primary Metabolites and Fisher's Analysis.

Authors:  Xian-Rui Wang; Ting-Ting Cao; Xue-Mei Tian; Hui Wang; Yun Wang
Journal:  Comput Math Methods Med       Date:  2022-01-22       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.